The chip maker Nvidia (+ 1.7% to 531.4) reached an all-time high closing Monday after unveiling new graphics processors taking advantage of artificial intelligence.
United Airlines (+ 1.44% to 43.54) and Alaska Air (-1.4% to 37.34) both declared having detected “poorly attached equipment” on certain MAX 9 aircraft held for inspection. Boeing lost another 1.41% to 225.76 after dropping 8% on Monday.
According to the Wall Street Journal, Hewlett Packard Company (- 8.92% to 16.14) would be in advanced talks to buy back Juniper Networks (+ 21.81% to 36.81) for around $13 billion.
The U.S. government will issue a ruling this week that will make it harder for companies to treat workers as independent contractors rather than employees. The actions ofUber Technologies (+ 2.19% to 60.3), Lyft (- 0.44% to 13.49) and Doordash (+4.6% to 103.05) had fallen by at least 10% when the draft rule was proposed in October 2022.
The chip maker Microchip Technology (- 0.35% to 85.34) revised downwards its turnover forecasts for the 3th fiscal quarter, citing the weakening economic environment.
Urban Outfitters rose 7.74% to 38.68 as the group said its net sales for the two months ended December 31 were up 10% year-on-year.
Jefferies Financial (-2.04% to 39.86) announced a 53% drop in fourth-quarter profit as continued economic uncertainty dampened transactions.
Eversource Energy (-7.75% to 58) recorded an impairment charge of between $1.4 and $1.6 billion in the fourth quarter of 2023 linked to certain wind projects.
Match Group gained 3.04% to 39.04, the activist investor Elliott Investment Management having taken a stake of around a billion dollars in the company in order to rebound the stock price.
The software provider Unity Software (- 7.95% to 35.88) plans to lay off around 25% of its workforce, or 1,800 jobs.
Eli Lilly (-0.09% to 625.48) said new prescriptions for its weight-loss drug Zepbound reached 25,000 per week at the end of December and that supply may not satisfy all of demand in 2024.
Pfizer (-0.61% to 29.4) will remain aggressive in its attempts to penetrate the lucrative obesity market, CEO Albert Bourla said on Monday.
Biogen (- 0.83% to 255.84) and Eisai (+1.42% to 12.85) said their treatment for Alzheimer’s disease, Leqembi, had been approved in China, the third country to do so after the United States and Japan.
Netflix fell 0.61% to 482.09, while Citi lowered its Buy recommendation to Neutral.
Axonics dropped 0.45% to 69.05, penalized by RBC which revised downwards its recommendation from Outperform to Online Performance.
THE Dow Jones thus lost 0.42% to 37,525.16 points, the Nasdaq Composite took 0.09% to 14,857.71 points and the S&P 500 dropped 0.15% to 4,756.50 points.
■
